Neurodegenerative diseases like Alzheimer’s or Parkinson’s Disease affect millions of people worldwide. Although current treatments may help relieve some of the physical or mental symptoms, there is still no way to slow disease progression and no known cures. NanoTemper is committed to providing new solutions for studying these diseases and developing new treatments. This webinar will show how aggregation of intrinsically disordered proteins is a common characteristic of all neurodegenerative disorders and also how NanoTemper’s instruments can overcome the challenges of other technologies when studying them.
Characterize the molecular mechanisms of neurodegenerative diseases
Learn howSee more related content
Use this eBook to advance your own neurodegenerative diseases (ND) research by reading a selection of peer-reviewed publications. Find out how researchers are gaining insight into the molecular mechan
![Can bioanalytical tools solve your neurodegenerative disease research challenges? 4 questions to ask yourself](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fnanotempertech.com%2Fwp-content%2Fuploads%2F2021%2F01%2FBrain-Featured-Image-2.png&size=1&version=1720526038&sig=9de406baa3798c0b2f62b0130c5e7289&default=hubs%2Ftilebg-blogs.jpg)
Certain proteins and interactions are just inherently difficult to study. Bioanalytical tools — with the right capabilities — can help you overcome these limitations. To solve your...
![4 ways to help you overcome the limitations of current methods in neurodegenerative disease research](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlYWM2MDlkZGQwODUuanBnJnZlcnNpb249MDAwMCZzaWc9ODBmMTQ3MzkxNTU0NGI4MDlhZGQyYTc3MmVjMjAyZDY%25253D&size=1&version=1665679078&sig=ba8bdad56d5f6d0ddc6e5f61bd329332&default=hubs%2Ftilebg-blogs.jpg)
![Characterize the true nature of intrinsically disordered proteins without immobilizing them](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fnanotempertech.com%2Fwp-content%2Fuploads%2F2020%2F10%2FBird-watching-Featured-Image.png&size=1&version=1720526038&sig=297ec2299b21ab669795c3bfeeb27aa9&default=hubs%2Ftilebg-blogs.jpg)
If you study neurodegenerative diseases (ND), you already know they are one of the most challenging — and fascinating — types of diseases to study. With protein aggregation being a hallmark of ND,...
![These 7 key proteins may hold the key to effective therapies for neurodegenerative diseases](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fnanotempertech.com%2Fwp-content%2Fuploads%2F2020%2F05%2Fkeys-locks-Featured-Image.png&size=1&version=1720526039&sig=f49445a8b3826b1b914aeb45aae59688&default=hubs%2Ftilebg-blogs.jpg)
While the processes involved in the genesis and accumulation of misfolded proteins were initially thought to be distinct for each disease, advancements in technology have allowed scientists to...
![3 biggest challenges in neurodegenerative disease research and why you should focus on them](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fnanotempertech.com%2Fwp-content%2Fuploads%2F2020%2F04%2FFocus-Featured_Image.png&size=1&version=1665679078&sig=916d588f39a15aa2dd24cc29f94fed31&default=hubs%2Ftilebg-blogs.jpg)
Neurodegenerative diseases (ND) are very complex disorders. Not only is each one different, displaying unique combinations of symptoms and progressing at varying rates, but the biochemical...
![10 ways to fund your neurodegenerative disease research (that aren’t just the government)](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fnanotempertech.com%2Fwp-content%2Fuploads%2F2020%2F04%2FFunding-Featured-Image.png&size=1&version=1720526039&sig=e04d98c6594fcb069ff0605ef3801fd1&default=hubs%2Ftilebg-blogs.jpg)
It may make sense to look beyond traditional governmental sources like the National Institute of Health and the National Science Foundation and consider alternative funding options. Here are some...
![Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlODY0ZGE3OGRkMWQucG5nJnZlcnNpb249MDAwMCZzaWc9Zjk4OWMyOThhMWY2Zjg1OWVhZTQ1NGIyNzg4YzJiNjk%25253D&size=1&version=1665679078&sig=9f10d1d3dbdf65821e89290b8b4eddf7&default=hubs%2Ftilebg-blogs.jpg)
![New peptide inhibitors modulate the self-assembly of islet amyloid polypeptide residues 11–20 in vitro](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlODY1ZGI2NmFmODIucG5nJnZlcnNpb249MDAwMCZzaWc9M2M3NzFkZDg5ZDhkNTA1Yzk1Y2Y5MDg0NTY1MDEyYzY%25253D&size=1&version=1665679078&sig=62bd198172d04172d2b490d0ffc5b4a1&default=hubs%2Ftilebg-blogs.jpg)
![Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of ß-amyloid peptide](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlODY1OGEwMzU0MmUucG5nJnZlcnNpb249MDAwMCZzaWc9MGY4YTBkN2ViMGVhNDljZTY2YjUzMzY5ODdlMDFkNDY%25253D&size=1&version=1665679078&sig=59f7b4972de971aedfd0fb3f2bf8f522&default=hubs%2Ftilebg-blogs.jpg)
![An engineered monomer binding-protein for alpha-syn efficiently inhibits the proliferation of amyloid fibrils](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlODY1YWU5YTc5ZTIucG5nJnZlcnNpb249MDAwMCZzaWc9YWIxNTAzNGQxZTA3NDczMGMyYzkzMTc5ZDI3NzQxN2U%25253D&size=1&version=1665679078&sig=d8843a06f456d24b7841bf4f5cad98f8&default=hubs%2Ftilebg-blogs.jpg)
![A small compound targeting prohibitin with potential interest for cognitive deficit rescue in aging mice and tau pathology treatment](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlODY2OTIyOGNkODIucG5nJnZlcnNpb249MDAwMCZzaWc9MjZkMmY1MzEwOWU3Y2U3ZDk2ZmEwYWVjNmM3YTdlYmQ%25253D&size=1&version=1665679078&sig=033900d7a726982e4a66cdeec5da1873&default=hubs%2Ftilebg-blogs.jpg)
![The voltage-dependent anion channel 1 mediates amyloid ß toxicity and represents a potential target for AD therapy](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTg2NTQ5JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlODY2ZWMxNmRiZDYucG5nJnZlcnNpb249MDAwMCZzaWc9MDM5MGM4NjkxN2JhYTNiNWE5MGU4NTc5YzcyZmQ2ODE%25253D&size=1&version=1665679078&sig=8b80a3f95842f6ce0e939c9d4af037ed&default=hubs%2Ftilebg-blogs.jpg)